Wide Ranks

HCWB

HCW Biologics Inc.

0.5021

Top Statistics
Market Cap 22 M Forward PE -0.9129 Revenue Growth -0.60 %
Current Ratio 0.10 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.5470 Enterprise / Revenue 5.10 Price To Sales Trailing12 Months 5.70
Profitability
Profit Margins 0.00 % Operating Margins -2235.75 %
Balance Sheet
Total Cash 1 M Total Cash Per Share 0.0310 Total Debt 10 M
Total Debt To Equity Current Ratio 0.10 Book Value Per Share 0.3740
All Measures
Short Ratio 28.00 % Message Board Id finmb_628452149 Fax 954 842 2037
Shares Short Prior Month 28052 Return On Equity -3.44 City Miramar
Uuid b3a1f8f3-abd3-3094-b85a-96025340ef4b Previous Close 0.5584 First Trade Date Epoch Utc 1 B
Book Value 0.3740 Beta 0.8380 Total Debt 10 M
Volume 864694 Price To Book 1.34 Fifty Two Week Low 0.2760
Total Cash Per Share 0.0310 Total Revenue 3 M Shares Short Previous Month Date 1 B
Target Median Price 3.00 Max Age 86400 Recommendation Mean 2.00
Sand P52 Week Change 0.3133 Operating Margins -2235.75 % Target Mean Price 3.00
Net Income To Common -38367424 Short Percent Of Float 0.0004 Implied Shares Outstanding 44 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 58 M
Average Volume10days 58 M Total Cash 1 M Next Fiscal Year End 1 B
Revenue Per Share 0.1070 Held Percent Insiders 0.5230 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 0.5584
Target Low Price 3.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 0.5278
Open 0.5344 Free Cashflow -6026586 State FL
Dividend Yield 0.00 % Return On Assets -0.7009 Time Zone Short Name EST
Trailing Eps -1.01 Day Low 0.4880 Address1 2929 North Commerce Parkway
Shares Outstanding 44 M Price Hint 4 Target High Price 3.00
Website https://www.hcwbiologics.com 52 Week Change -0.5352 Average Volume 9 M
Forward Eps -0.5500 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 7.80 % Is_sp_500 False Regular Market Day High 0.5600
Profit Margins 0.00 % Fifty Two Week High 2.52 Day High 0.5600
Shares Short 8092 Regular Market Open 0.5344 Industry Key biotechnology
Earnings Growth 0.00 % Enterprise To Revenue 5.10 Revenue Growth -0.60 %
Shares Percent Shares Out 0.0002 Operating Cashflow -17950138 Currency USD
Time Zone Full Name America/New_York Market Cap 22 M Is_nasdaq_100 False
Zip 33025 Quote Type EQUITY Industry Biotechnology
Long Name HCW Biologics Inc. Regular Market Day Low 0.4880 Held Percent Institutions 0.0313
Current Price 0.5021 Enterprise To Ebitda -0.5470 Financial Currency USD
Current Ratio 0.10 Gross Margins -102.67 % Industry Disp Biotechnology
Number Of Analyst Opinions 1 Country United States Float Shares 17 M
Two Hundred Day Average 0.9167 Enterprise Value 20 M Price To Sales Trailing12 Months 5.70
Forward PE -0.9129 Regular Market Volume 864694 Ebitda -36577048
Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States.

The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases.

It also develops HCW9201, a cell-based therapy that is in Phase I clinical trials for the treatment of patients with relapsed/refractory acute myelogenous leukemia; and HCW9206, an injectable immunotherapeutic to use as adjuvant for adoptive cell therapy in cancer treatment.

The company was incorporated in 2018 and is headquartered in Miramar, Florida.